Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-17 Sale |
2024-06-18 9:45 pm |
ADC Therapeutics SA | ADCT | Azelby Robert Director |
6,995 | $2.89 | $20,216 | 53,005 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-20 Option Award |
2025-02-24 6:05 pm |
N/A 2035-02-19 |
Terns Pharmaceuticals Inc. | TERN | Azelby Robert Director |
90,000 | $0 | 90,000 (Direct) |
View |
| 2024-11-06 Option Award |
2024-11-07 4:51 pm |
N/A N/A |
CARDINAL HEALTH INC | CAH | Azelby Robert Director |
1,730 | $0 | 3,018 (Direct) |
View |
| 2024-06-13 Option Award |
2024-06-14 5:46 pm |
N/A N/A |
ADC Therapeutics SA | ADCT | Azelby Robert Director |
40,000 | $0 | 60,000 (Direct) |
View |
| 2024-03-15 Option Award |
2024-03-18 5:48 pm |
N/A N/A |
CARDINAL HEALTH INC | CAH | Azelby Robert Director |
1,288 | $0 | 1,288 (Direct) |
View |
Ownership |
2024-01-02 8:06 pm |
N/A N/A |
ADC Therapeutics SA | ADCT | Azelby Robert Director |
0 | $0 | 51,000 (Direct) |
View |
| 2023-04-10 Option Award |
2023-04-12 4:59 pm |
N/A 2033-04-09 |
CHINOOK THERAPEUTICS INC. | KDNY | Azelby Robert Director |
35,200 | $0 | 35,200 (Direct) |
View |
| 2022-10-31 Option Award |
2022-11-02 7:09 pm |
N/A 2032-10-30 |
Eliem Therapeutics Inc. | ELYM | Azelby Robert President & CEO |
500,000 | $0 | 500,000 (Direct) |
View |
| 2022-01-27 Option Award |
2022-01-31 5:13 pm |
N/A 2032-01-26 |
Eliem Therapeutics Inc. | ELYM | Azelby Robert President & CEO |
500,000 | $0 | 500,000 (Direct) |
View |
Ownership |
2021-08-09 6:02 pm |
N/A 2031-02-25 |
Eliem Therapeutics Inc. | ELYM | Azelby Robert Chief Executive Officer |
0 | $0 | 1,190,462 (Direct) |
View |
| 2021-06-10 Option Award |
2021-06-11 9:07 pm |
N/A 2031-06-10 |
Clovis Oncology Inc. | CLVS | Azelby Robert Director |
42,223 | $0 | 42,223 (Direct) |
View |
| 2020-06-18 Option Award |
2020-06-22 5:19 pm |
2021-06-18 2030-06-18 |
IMMUNOMEDICS INC | IMMU | Azelby Robert Director |
10,258 | $0 | 10,258 (Direct) |
View |
| 2020-06-04 Option Award |
2020-06-05 4:55 pm |
N/A 2030-06-04 |
Clovis Oncology Inc. | CLVS | Azelby Robert Director |
40,138 | $0 | 40,138 (Direct) |
View |